Compare the differences that matter

Clinical context: [1] [3] [5] [7] [9]

How enclomiphene and TRT work

Enclomiphene also is not identical to Clomid. Clomiphene citrate, commonly known as Clomid, contains both enclomiphene and zuclomiphene. Results or approval information for one medication should not automatically be applied to the other. [4]

Who might be considered for each approach?

The cause of low testosterone comes before the choice of medication. In primary hypogonadism, the testes cannot produce enough testosterone despite stimulation. Asking them to work harder may not solve that problem. In secondary hypogonadism, signals from the brain or pituitary are reduced or inappropriate for the testosterone level; the cause and remaining capacity to respond still need evaluation. [3]

An enclomiphene discussion may be relevant when preserving sperm production is a priority and testing suggests responsive secondary hypogonadism. A pituitary disorder or other underlying illness may require a different approach. The drug should not be assumed suitable simply because someone is young or wants to avoid injections. [8]

TRT may be considered when confirmed deficiency warrants replacement and the benefits outweigh the risks. A consultation should also address whether sleep, medications, weight-related health problems, or another condition could be contributing to symptoms.

For the broader evaluation process, read NovaGenix's testosterone replacement guide.

Fertility can change the treatment decision

If you want children now or in the future, mention that before starting treatment. A better testosterone result does not necessarily mean better sperm production.

In two phase III trials involving overweight men with secondary hypogonadism, enclomiphene and testosterone gel increased testosterone. Enclomiphene maintained sperm concentrations, while the gel group experienced reduced sperm production over the 16-week study period. These findings support a potential role in selected patients; they do not establish pregnancy or live-birth outcomes. [1]

Review TRT and fertility considerations for a fuller discussion of testing, sperm banking, and specialist care. If you are considering an additional medication with TRT, the combination section below explains the rationale and how to assess its potential role.

Enclomiphene and TRT together: why some physicians consider a combined approach

Treatment discussions can address both symptom relief and your goals for future testicular function. Some physicians consider adding enclomiphene or clomiphene to TRT with the aim of supporting the body's own hormone signaling alongside testosterone replacement. For patients concerned about sperm production or changes in testicular size, understanding that rationale can make the consultation more useful.

Two mechanisms, an individualized treatment goal

TRT supplies testosterone directly. Enclomiphene acts further upstream, encouraging LH and FSH release in men whose hormone system can respond. The proposed benefit of combining them is to pair testosterone replacement with stimulation of those signals. The Plastic Surgery Key overview describes this rationale and the importance of tailoring care to the patient; it is an educational discussion, not a trial demonstrating combination outcomes.

What research supports—and what remains uncertain

Studies of enclomiphene used by itself show that it can raise testosterone and stimulate LH and FSH in selected men with secondary hypogonadism. That provides a biological rationale for interest in the medication, but does not establish the same response during ongoing TRT, which suppresses those signals. [2]

The AUA/ASRM guideline finds the evidence for preserving sperm production by adding hCG or combinations involving SERMs and other hormones to testosterone too limited to recommend that approach. Enclomiphene plus TRT therefore should not be presented as a proven way to maintain fertility or testicular size. [10]

Discuss the options with your physician

Clomiphene, enclomiphene, and hCG are different medications. SERMs affect feedback in the brain, while hCG acts at the testicular LH receptor; their roles and approval status differ. A supervised transition away from TRT is also a different situation from taking two medications together indefinitely.

A useful next step is a conversation about your goals and results. Ask what benefit an additional prescription is intended to provide, what alternatives exist, and how the physician will assess whether it is helping. If pregnancy is a current priority, discuss a fertility-focused plan and possible reproductive-urology referral. Read NovaGenix's TRT and fertility guide. Do not change an existing prescription on your own.

Which works better for symptoms and testosterone levels?

Laboratory improvement and feeling better are related questions, but they are not the same outcome. Some enclomiphene trials demonstrated increases in testosterone comparable to topical testosterone in selected men. Those results cannot establish that enclomiphene matches injections, gels, or other TRT products for every symptom or patient. [2]

TRT has randomized-trial evidence for certain symptom benefits. For example, the Testosterone Trials studied symptomatic men aged 65 or older with low testosterone: treatment improved sexual function, but did not significantly improve the primary vitality outcome. That study does not mean every younger man will have the same response, or that fatigue always responds to testosterone. [6]

For enclomiphene, the evidence is more developed for hormone levels and sperm parameters than for sustained improvements in how patients feel and function. Long-term comparative safety also remains uncertain. [9]

Agree on what improvement would matter to you: sexual desire, a particular symptom affecting daily life, or a fertility-related goal. If the lab value rises but the original problem persists, the plan deserves reassessment rather than an automatic dose increase.

Side effects and safety

Enclomiphene considerations

Reported adverse effects may include headache, increased estradiol, and abdominal discomfort. Not everyone experiences side effects. SERM-related concerns also include visual symptoms and thromboembolic risk; enclomiphene's individual risk rates and long-term safety are not established as clearly as patients may assume. Do not interpret limited safety data as proof of fewer risks. [8] [9]

Report new visual disturbances promptly. Sudden vision loss, chest pain, or difficulty breathing warrants urgent medical assessment.

TRT considerations

Reported adverse effects may include increased hematocrit, acne, fluid retention, and sperm suppression. Not everyone experiences these effects. Formulation-specific precautions also apply, such as preventing transfer of topical testosterone to another person. Health history and the chosen product determine which precautions and monitoring are needed.

In 2025, FDA requested removal of the class-wide boxed-warning language about increased adverse cardiovascular outcomes after reviewing TRAVERSE, while requiring blood-pressure warnings. That change does not mean testosterone is risk-free or suitable for every patient. [7]

A comparison should therefore ask, “Which risks apply to me, and how will they be monitored?” rather than assume that an oral treatment is safer than an injectable one.

FDA approval and compounded prescriptions

Enclomiphene is not an FDA-approved standalone U.S. medication. Describing it only as “off-label” can obscure that distinction: off-label use ordinarily refers to an approved drug being prescribed outside its approved labeling. [4] [9]

Compounded medications are not reviewed by FDA for safety, effectiveness, or quality before marketing. They can serve particular patient needs, but a pharmacy prescription does not make a compounded product equivalent to an FDA-approved drug. Ask what exact product is being prescribed, why it is being considered, and what alternatives exist. [5]

Testing and follow-up before making a choice

Symptoms alone—or one borderline laboratory result—are not enough to establish testosterone deficiency. Evaluation generally includes repeat morning testosterone testing, with LH and FSH helping distinguish the source of the problem. Other tests depend on the findings. [3]

Bring prior hormone results, your medication and supplement list, previous treatment details, and your fertility plans. Ask:

• What explains my low result, and does that explanation fit my symptoms?
• What would make enclomiphene unlikely to work for me?
• Which benefits are supported by evidence for someone like me?
• What tests and follow-up visits will this treatment require?
• What will we do if levels improve but symptoms do not?

Follow-up is part of either approach. Testing must be interpreted in relation to the prescribed treatment and timing. An internet dosing schedule cannot account for those differences.

Enclomiphene vs. TRT cost: the value of experienced care

Cost matters when choosing treatment. So does having a physician who understands your symptoms, explains your results, and helps you make confident decisions about your health.

At NovaGenix, your care is about more than a prescription. You benefit from the clinical guidance of Timothy Mackey, D.O., a physician with more than two decades in clinical practice. His experience helps guide the questions that matter: why your testosterone is low, which treatment may fit your needs, and how to assess your response over time.

NovaGenix's 4.9-star Google rating and BBB A+ rating and accreditation offer additional information as you get to know the practice. You can explore those independent profiles alongside Dr. Mackey's credentials when deciding where to seek care.

Whether you are exploring treatment for the first time or reviewing an existing plan, we welcome your questions. The team will explain your recommended care, what is included, and any separate costs before you begin. Fertility goals receive individual attention; protecting sperm production may require testing or specialist coordination.

Talk with NovaGenix about your treatment options and costs.

Frequently asked questions